Impact of 18-Month Soy Protein Supplementation on Steroid Hormones and Serum Biomarkers of Angiogenesis, Apoptosis, and the Growth Hormone/IGF-1 Axis: Results of a Randomized, Placebo-Controlled Trial in Males Following Prostatectomy

References

• Nachvak SM, Moradi S, Anjom-Shoae J, Rahmani J, Nasiri M, Maleki V, Sadeghi O. Soy, soy isoflavones, and protein intake in relation to mortality from all causes, cancers, and cardiovascular diseases: a systematic review and dose-response meta-analysis of prospective cohort studies. J Acad Nutr Diet. 2019;119(9):1483–500.e17. doi:https://doi.org/10.1016/j.jand.2019.04.011
   PubMed Web of Science ®Google Scholar
• Namazi N, Saneei P, Larijani B, Esmaillzadeh A. Soy product consumption and the risk of all-cause, cardiovascular and cancer mortality: a systematic review and meta-analysis of cohort studies. Food Funct. 2018;9(5):2576–88. doi:https://doi.org/10.1039/c7fo01622k
   PubMed Web of Science ®Google Scholar
• Applegate CC, Rowles JL, Ranard KM, Jeon S, Erdman JW. Soy consumption and the risk of prostate cancer: an updated systematic review and meta-analysis. Nutrients. 2018;10(1):40. doi:https://doi.org/10.3390/nu10010040
   PubMed Web of Science ®Google Scholar
• Hwang YW, Kim SY, Jee SH, Kim YN, Nam CM. Soy food consumption and risk of prostate cancer: a meta-analysis of observational studies. Nutr Cancer. 2009;61(5):598–606. doi:https://doi.org/10.1080/01635580902825639
   PubMed Web of Science ®Google Scholar
• van Die MD, Bone KM, Williams SG, Pirotta MV. Soy and soy isoflavones in prostate cancer: a systematic review and meta-analysis of randomized controlled trials. BJU Int. 2014;113(5b):E119–130. doi:https://doi.org/10.1111/bju.12435
   PubMed Web of Science ®Google Scholar
• Yan L, Spitznagel EL. Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr. 2009;89(4):1155–63. doi:https://doi.org/10.3945/ajcn.2008.27029
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang K, Chen L, Yin B, Song Y. Is phytoestrogen intake associated with decreased risk of prostate cancer? A systematic review of epidemiological studies based on 17,546 cases. Andrology. 2016;4(4):745–56. doi:https://doi.org/10.1111/andr.12196
   PubMed Web of Science ®Google Scholar
• Fritz H, Seely D, Flower G, Skidmore B, Fernandes R, Vadeboncoeur S, Kennedy D, Cooley K, Wong R, Sagar S, et al. Soy, red clover, and isoflavones and breast cancer: a systematic review. PLoS One. 2013;8(11):e81968: doi:https://doi.org/10.1371/journal.pone.0081968
   PubMed Web of Science ®Google Scholar
• Zhang G-Q, Chen J-L, Liu Q, Zhang Y, Zeng H, Zhao Y. Soy intake is associated with lower endometrial cancer risk: a systematic review and meta-analysis of observational studies. Medicine (Baltimore)). 2015;94(50):e2281 doi:https://doi.org/10.1097/MD.0000000000002281
   PubMed Web of Science ®Google Scholar
• Zhong X-S, Ge J, Chen S-W, Xiong Y-Q, Ma S-J, Chen Q. Association between dietary isoflavones in soy and legumes and endometrial cancer: a systematic review and meta-analysis. J Acad Nutr Diet. 2018;118(4):637–51. doi:https://doi.org/10.1016/j.jand.2016.09.036
   PubMed Web of Science ®Google Scholar
• Lu D, Pan C, Ye C, Duan H, Xu F, Yin L, Tian W, Zhang S. Meta-analysis of soy consumption and gastrointestinal cancer risk. Sci Rep. 2017;7(1):4048 doi:https://doi.org/10.1038/s41598-017-03692-y
   PubMed Web of Science ®Google Scholar
• Weng KG, Yuan YL. Soy food intake and risk of gastric cancer: a dose-response meta-analysis of prospective studies. Medicine (Baltimore)). 2017;96(33):e7802 doi:https://doi.org/10.1097/MD.0000000000007802
   PubMed Web of Science ®Google Scholar
• Yu Y, Jing X, Li H, Zhao X, Wang D. Soy isoflavone consumption and colorectal cancer risk: a systematic review and meta-analysis. Sci Rep. 2016;6:25939. doi:https://doi.org/10.1038/srep25939
   PubMed Web of Science ®Google Scholar
• Jiang R, Botma A, Rudolph A, Hüsing A, Chang-Claude J. Phyto-oestrogens and colorectal cancer risk: a systematic review and dose-response meta-analysis of observational studies. Br J Nutr. 2016;116(12):2115–28. doi:https://doi.org/10.1017/S0007114516004360
   PubMed Web of Science ®Google Scholar
• Li N, Wu X, Zhuang W, Xia L, Chen Y, Zhao R, Yi M, Wan Q, Du L, Zhou Y, et al. Soy and isoflavone consumption and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomized trials in humans. Mol Nutr Food Res. 2020;64(4):e1900751: doi:https://doi.org/10.1002/mnfr.201900751
   PubMed Web of Science ®Google Scholar
• Miyanaga N, Akaza H, Hinotsu S, Fujioka T, Naito S, Namiki M, Takahashi S, Hirao Y, Horie S, Tsukamoto T, et al. Prostate cancer chemoprevention study: an investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen. Cancer Sci. 2012;103(1):125–30.: doi:https://doi.org/10.1111/j.1349-7006.2011.02120.x
   PubMed Web of Science ®Google Scholar
• Quaas AM, Kono N, Mack WJ, Hodis HN, Felix JC, Paulson RJ, Shoupe D. Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled trial. Menopause. 2013;20(8):840–4. doi:https://doi.org/10.1097/GME.0b013e3182804353
   PubMed Web of Science ®Google Scholar
• Bosland MC, Kato I, Zeleniuch-Jacquotte A, Schmoll J, Enk Rueter E, Melamed J, Kong MX, Macias V, Kajdacsy-Balla A, Lumey LH, et al. Effect of soy protein isolate supplementation on biochemical recurrence of prostate cancer after radical prostatectomy: a randomized trial. Jama. 2013;310(2):170–8.: doi:https://doi.org/10.1001/jama.2013.7842
   PubMed Web of Science ®Google Scholar
• Maskarinec G, Takata Y, Franke AA, Williams AE, Murphy SP. A 2-year soy intervention in premenopausal women does not change mammographic densities. J Nutr. 2004;134(11):3089–94. doi:https://doi.org/10.1093/jn/134.11.3089
   PubMed Web of Science ®Google Scholar
• Verheus M, van Gils CH, Kreijkamp-Kaspers S, Kok L, Peeters PHM, Grobbee DE, van der Schouw YT. Soy protein containing isoflavones and mammographic density in a randomized controlled trial in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2008;17(10):2632–8. doi:https://doi.org/10.1158/1055-9965.EPI-08-0344
   PubMed Web of Science ®Google Scholar
• Maskarinec G, Verheus M, Steinberg FM, Amato P, Cramer MK, Lewis RD, Murray MJ, Young RL, Wong WW. Various doses of soy isoflavones do not modify mammographic density in postmenopausal women. J Nutr. 2009;139(5):981–6. doi:https://doi.org/10.3945/jn.108.102913
   PubMed Web of Science ®Google Scholar
• Delmanto A, Nahas-Neto J, Traiman P, Uemura G, Pessoa EC, Nahas EAP. Effects of soy isoflavones on mammographic density and breast parenchyma in postmenopausal women: a randomized, double-blind, placebo-controlled clinical trial. Menopause. 2013;20(10):1049–54. doi:https://doi.org/10.1097/GME.0b013e3182850270
   PubMed Web of Science ®Google Scholar
• Wu AH, Spicer D, Garcia A, Tseng C-C, Hovanessian-Larsen L, Sheth P, Martin SE, Hawes D, Russell C, MacDonald H, et al. Double-blind randomized 12-month soy intervention had no effects on breast mri fibroglandular tissue density or mammographic density. Cancer Prev Res (Phila)). 2015;8(10):942–51.: doi:https://doi.org/10.1158/1940-6207.CAPR-15-0125
   PubMed Web of Science ®Google Scholar
• Khan SA, Chatterton RT, Michel N, Bryk M, Lee O, Ivancic D, Heinz R, Zalles CM, Helenowski IB, Jovanovic BD, et al. Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial. Cancer Prev Res (Phila)). 2012;5(2):309–19.: doi:https://doi.org/10.1158/1940-6207.CAPR-11-0251
   PubMed Web of Science ®Google Scholar
• McMichael-Phillips DF, Harding C, Morton M, Roberts SA, Howell A, Potten CS, Bundred NJ. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. Am J Clin Nutr. 1998;68(6):1431S–5S. doi:https://doi.org/10.1093/ajcn/68.6.1431S
   PubMed Web of Science ®Google Scholar
• Fleshner NE, Kapusta L, Donnelly B, Tanguay S, Chin J, Hersey K, Farley A, Jansz K, Siemens DR, Trpkov K, et al. Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium. J Clin Oncol. 2011;29(17):2386–90. doi:https://doi.org/10.1200/JCO.2010.32.0994
   PubMed Web of Science ®Google Scholar
• Steinberg FM, Murray MJ, Lewis RD, Cramer MA, Amato P, Young RL, Barnes S, Konzelmann KL, Fischer JG, Ellis KJ, et al. Clinical outcomes of a 2-y soy isoflavone supplementation in menopausal women. Am J Clin Nutr. 2011;93(2):356–67.: doi:https://doi.org/10.3945/ajcn.110.008359
   PubMed Web of Science ®Google Scholar
• Mahmoud AM, Yang W, Bosland MC. Soy isoflavones and prostate cancer: a review of molecular mechanisms. J Steroid Biochem Mol Biol. 2014;140:116–32. doi:https://doi.org/10.1016/j.jsbmb.2013.12.010
   PubMed Web of Science ®Google Scholar
• Spagnuolo C, Russo GL, Orhan IE, Habtemariam S, Daglia M, Sureda A, Nabavi SF, Devi KP, Loizzo MR, Tundis R, et al. Genistein and cancer: current status, challenges, and future directions. Adv Nutr. 2015;6(4):408–19. doi:https://doi.org/10.3945/an.114.008052
   PubMed Web of Science ®Google Scholar
• Tuli HS, Tuorkey MJ, Thakral F, Sak K, Kumar M, Sharma AK, Sharma U, Jain A, Aggarwal V, Bishayee A, et al. Molecular mechanisms of action of genistein in cancer: recent advances. Front Pharmacol. 2019;10:1336. doi:https://doi.org/10.3389/fphar.2019.01336
   PubMed Web of Science ®Google Scholar
• Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst. 2000;92(18):1472–89. doi:https://doi.org/10.1093/jnci/92.18.1472
   PubMed Web of Science ®Google Scholar
• Dupont J, Pierre A, Froment P, Moreau C. The insulin-like growth factor axis in cell cycle progression. Horm Metab Res. 2003;35(11–12):740–50. doi:https://doi.org/10.1055/s-2004-814162
   PubMed Web of Science ®Google Scholar
• Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004;363(9418):1346–53. doi:https://doi.org/10.1016/S0140-6736(04)16044-3
   PubMed Web of Science ®Google Scholar
• Nadal C, Maurel J, Gallego R, Castells A, Longarón R, Marmol M, Sanz S, Molina R, Martin-Richard M, Gascón P, et al. FAS/FAS ligand ratio: a marker of oxaliplatin-based intrinsic and acquired resistance in advanced colorectal cancer. Clin Cancer Res. 2005;11(13):4770–4. doi:https://doi.org/10.1158/1078-0432.CCR-04-2119
   PubMed Web of Science ®Google Scholar
• Mouawad R, Khayat D, Soubrane C. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in advanced melanoma. Melanoma Res. 2000;10:461–7.
   PubMed Web of Science ®Google Scholar
• Ugurel S, Rebmann V, Ferrone S, Tilgen W, Grosse-Wilde H, Reinhold U. Soluble human leukocyte antigen–G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer. 2001;92(2):369–3676. doi:https://doi.org/10.1002/1097-0142(20010715)92:2<369::AID-CNCR1332>3.0.CO;2-U
   PubMed Web of Science ®Google Scholar
• Bertolini F, Paolucci M, Peccatori F, Cinieri S, Agazzi A, Ferrucci PF, Cocorocchio E, Goldhirsch A, Martinelli G. Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma. Br J Haematol. 1999;106(2):504–9. doi:https://doi.org/10.1046/j.1365-2141.1999.01547.x
   PubMed Web of Science ®Google Scholar
• McMeekin DS, Sill MW, Darcy KM, Stearns-Kurosawa DJ, Webster K, Waggoner S, Benbrook D. A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a gynecologic oncology group study. Gynecol Oncol. 2007;106(3):596–603. doi:https://doi.org/10.1016/j.ygyno.2007.05.013
   PubMed Web of Science ®Google Scholar
• Nagata C, Takatsuka N, Shimizu H, Hayashi H, Akamatsu T, Murase K. Effect of soymilk consumption on serum estrogen and androgen concentrations in Japanese men. Cancer Epidemiol Biomarkers Prev. 2001;10(3):179–84.
   PubMed Web of Science ®Google Scholar
• Kumar NB, Cantor A, Allen K, Riccardi D, Besterman-Dahan K, Seigne J, Helal M, Salup R, Pow-Sang J. The specific role of isoflavones in reducing prostate cancer risk. Prostate. 2004;59(2):141–7. doi:https://doi.org/10.1002/pros.10362
   PubMed Web of Science ®Google Scholar
• Dalais FS, Meliala A, Wattanapenpaiboon N, Frydenberg M, Suter DAI, Thomson WK, Wahlqvist ML. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer. Urology. 2004;64(3):510–5. doi:https://doi.org/10.1016/j.urology.2004.04.009
   PubMed Web of Science ®Google Scholar
• Dillingham BL, McVeigh BL, Lampe JW, Duncan AM. Soy protein isolates of varying isoflavone content exert minor effects on serum reproductive hormones in healthy young men. J Nutr. 2005;135(3):584–91. doi:https://doi.org/10.1093/jn/135.3.584
   PubMed Web of Science ®Google Scholar
• Goldin BR, Brauner E, Adlercreutz H, Ausman LM, Lichtenstein AH. Hormonal response to diets high in soy or animal protein without and with isoflavones in moderately hypercholesterolemic subjects. Nutr Cancer. 2005;51(1):1–6. doi:https://doi.org/10.1207/s15327914nc5101_1
   PubMed Web of Science ®Google Scholar
• Maskarinec G, Morimoto Y, Hebshi S, Sharma S, Franke AA, Stanczyk FZ. Serum prostate-specific antigen but not testosterone levels decrease in a randomized soy intervention among men. Eur J Clin Nutr. 2006;60(12):1423–9. doi:https://doi.org/10.1038/sj.ejcn.1602473
   PubMed Web of Science ®Google Scholar
• Kwan W, Duncan G, Van Patten C, Liu M, Lim J. A phase II trial of a soy beverage for subjects without clinical disease with rising prostate-specific antigen after radical radiation for prostate cancer. Nutr Cancer. 2010;62(2):198–207. doi:https://doi.org/10.1080/01635580903305318
   PubMed Web of Science ®Google Scholar
• Haun CT, Mobley CB, Vann CG, Romero MA, Roberson PA, Mumford PW, Kephart WC, Healy JC, Patel RK, Osburn SC, et al. Soy protein supplementation is not androgenic or estrogenic in college-aged men when combined with resistance exercise training. Sci Rep. 2018;8(1):11151. doi:https://doi.org/10.1038/s41598-018-29591-4
   PubMed Web of Science ®Google Scholar
• Hamilton-Reeves JM, Vazquez G, Duval SJ, Phipps WR, Kurzer MS, Messina MJ. Clinical studies show no effects of soy protein or isoflavones on reproductive hormones in men: results of a meta-analysis. Fertil Steril. 2010;94(3):997–1007. doi:https://doi.org/10.1016/j.fertnstert.2009.04.038
   PubMed Web of Science ®Google Scholar
• Mackey R, Ekangaki A, Eden JA. The effects of soy protein in women and men with elevated plasma lipids. Biofactors. 2000;12(1-4):251–7. doi:https://doi.org/10.1002/biof.5520120138
   PubMed Web of Science ®Google Scholar
• Hamilton-Reeves JM, Rebello SA, Thomas W, Slaton JW, Kurzer MS. Isoflavone-rich soy protein isolate suppresses androgen receptor expression without altering estrogen receptor-beta expression or serum hormonal profiles in men at high risk of prostate cancer. J Nutr. 2007;137(7):1769–75. doi:https://doi.org/10.1093/jn/137.7.1769
   PubMed Web of Science ®Google Scholar
• Pendleton JM, Tan WW, Anai S, Chang M, Hou W, Shiverick KT, Rosser CJ. Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy. BMC Cancer. 2008;8:132 doi:https://doi.org/10.1186/1471-2407-8-132
   PubMed Web of Science ®Google Scholar
• Lazarevic B, Boezelijn G, Diep LM, Kvernrod K, Ogren O, Ramberg H, Moen A, Wessel N, Berg RE, Egge-Jacobsen W, et al. Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind phase 2 clinical trial. Nutr Cancer. 2011;63(6):889–98.: doi:https://doi.org/10.1080/01635581.2011.582221
   PubMed Web of Science ®Google Scholar
• Kumar NB, Kang L, Pow-Sang J, Xu P, Allen K, Riccardi D, Besterman-Dahan K, Krischer JP. Results of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: administration prior to radical prostatectomy. J Soc Integr Oncol. 2010;8(1):3–13.
   PubMedGoogle Scholar
• Kumar NB, Pow-Sang J, Spiess P, Dickinson S, Schell MJ. A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomy. Oncotarget. 2020;11(14):1218–34. doi:https://doi.org/10.18632/oncotarget.27529
   PubMedGoogle Scholar
• Hamilton-Reeves JM, Rebello SA, Thomas W, Kurzer MS, Slaton JW. Effects of soy protein isolate consumption on prostate cancer biomarkers in men with HGPIN, ASAP, and low-grade prostate cancer. Nutr Cancer. 2007;60(1):7–13. doi:https://doi.org/10.1080/01635580701586770
   Web of Science ®Google Scholar
• Varinska L, Gal P, Mojzisova G, Mirossay L, Mojzis J. Soy and breast cancer: focus on angiogenesis. Int J Mol Sci. 2015;16(5):11728–49. doi:https://doi.org/10.3390/ijms160511728
   PubMed Web of Science ®Google Scholar
• Hamilton-Reeves JM, Banerjee S, Banerjee SK, Holzbeierlein JM, Thrasher JB, Kambhampati S, Keighley J, Van Veldhuizen P. Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial. PLoS One. 2013;8(7):e68331. doi:https://doi.org/10.1371/journal.pone.0068331
   PubMed Web of Science ®Google Scholar
• Arjmandi BH, Lucas EA, Khalil DA, Devareddy L, Smith BJ, McDonald J, Arquitt AB, Payton ME, Mason C. One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women. Nutr J. 2005;4(1):8. doi:https://doi.org/10.1186/1475-2891-4-8
   PubMed Web of Science ®Google Scholar
• Maskarinec G, Takata Y, Murphy SP, Franke AA, Kaaks R. Insulin-like growth factor-1 and binding protein-3 in a 2-year soya intervention among premenopausal women. Br J Nutr. 2005;94(3):362–7. doi:https://doi.org/10.1079/BJN20051525
   PubMed Web of Science ®Google Scholar
• Gann PH, Kazer R, Chatterton R, Gapstur S, Thedford K, Helenowski I, Giovanazzi S, Van Horn L. Sequential, randomized trial of a low-fat, high-fiber diet and soy supplementation: effects on circulating IGF-I and its binding proteins in premenopausal women. Int J Cancer. 2005;116(2):297–303. doi:https://doi.org/10.1002/ijc.21042
   PubMed Web of Science ®Google Scholar
• Maskarinec G, Ju D, Morimoto Y, Franke AA, Stanczyk FZ. Soy food intake and biomarkers of breast cancer risk: possible difference in Asian women? Nutr Cancer. 2017;69(1):146–53. doi:https://doi.org/10.1080/01635581.2017.1250924
   PubMed Web of Science ®Google Scholar
• Teas J, Irhimeh MR, Druker S, Hurley TG, Hébert JR, Savarese TM, Kurzer MS. Serum IGF-1 concentrations change with soy and seaweed supplements in healthy postmenopausal American women. Nutr Cancer. 2011;63(5):743–8. doi:https://doi.org/10.1080/01635581.2011.579383
   PubMed Web of Science ®Google Scholar
• Arjmandi BH, Khalil DA, Lucas EA, Smith BJ, Sinichi N, Hodges SB, Juma S, Munson ME, Payton ME, Tivis RD, et al. Soy protein may alleviate osteoarthritis symptoms. Phytomedicine. 2004;11(7–8):567–75. doi:https://doi.org/10.1016/j.phymed.2003.11.001
   PubMed Web of Science ®Google Scholar
• Khalil DA, Lucas EA, Juma S, Smith BJ, Payton ME, Arjmandi BH. Soy protein supplementation increases serum insulin-like growth factor-I in young and old men but does not affect markers of bone metabolism. J Nutr. 2002;132(9):2605–8. doi:https://doi.org/10.1093/jn/132.9.2605
   PubMed Web of Science ®Google Scholar
• Adams KF, Newton KM, Chen C, Emerson SS, Potter JD, White E, Lampe JW. Soy isoflavones do not modulate circulating insulin-like growth factor concentrations in an older population in an intervention trial. J Nutr. 2003;133(5):1316–9. doi:https://doi.org/10.1093/jn/133.5.1316
   PubMed Web of Science ®Google Scholar
• Ahn-Jarvis JH, Clinton SK, Grainger EM, Riedl KM, Schwartz SJ, Lee M-LT, Cruz-Cano R, Young GS, Lesinski GB, Vodovotz Y, et al. Isoflavone pharmacokinetics and metabolism after consumption of a standardized soy and soy-almond bread in men with asymptomatic prostate cancer. Cancer Prev Res (Phila)). 2015;8(11):1045–54. doi:https://doi.org/10.1158/1940-6207.CAPR-14-0465
   PubMed Web of Science ®Google Scholar
• Dewell A, Weidner G, Sumner MD, Barnard RJ, Marlin RO, Daubenmier JJ, Chi C, Carroll PR, Ornish D. Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the Prostate Cancer Lifestyle Trial. Nutr Cancer. 2007;58(1):35–42. doi:https://doi.org/10.1080/01635580701308034
   PubMed Web of Science ®Google Scholar
• Baer DJ, Stote KS, Paul DR, Harris GK, Rumpler WV, Clevidence BA. Whey protein but not soy protein supplementation alters body weight and composition in free-living overweight and obese adults. J Nutr. 2011;141(8):1489–94. doi:https://doi.org/10.3945/jn.111.139840
   PubMed Web of Science ®Google Scholar